Jul 18, 2018
CBHI Presents Innovative Sigma Anti-Bonding Calcium (SAC) In Medical Industry
Jul 13, 2018
Amgen And UCB Resubmit Biologics License Application (BLA) For EVENITY(TM) (romosozumab) To The US FDA
Jun 12, 2018
Grünenthal Initiates Pivotal Phase III Trials in Complex Regional Pain Syndrome
May 29, 2018
Bone Index: A Study Confirms - Bindex ® Point-of-care Technology is Extremely Cost-effective in Osteoporosis Management
Apr 20, 2018
The National Osteoporosis Foundation (NOF) Announces Dr. Joan Lappe as the 2018 Recipient of the Lawrence G. Raisz Memorial Lecture Award
Apr 02, 2018
The National Osteoporosis Foundation Announces Keynote Speakers for the Interdisciplinary Symposium on Osteoporosis (ISO18)
Feb 06, 2018
Global Osteoporosis Treatment Market 2017-2025: Bisphosphonates, Parathyroid Hormone Therapy, Calcitonin, SERM and Rank Ligand Inhibitors
Jan 08, 2018
European Medicines Agency Accepts Filing For EVENITY(TM) (Romosozumab)
Dec 08, 2017
National Osteoporosis Foundation Elects Elizabeth A. Thompson as its New CEO
Nov 16, 2017
Telephus Medical Founder Awarded $6 Million NIH Grant to Expand Translational Research in Bone Infections
Nov 09, 2017
New Data on FORTEO® (teriparatide [rDNA origin] injection) Showed Reduced Risk for New Vertebral and Clinical Fractures in Postmenopausal Women with Severe Osteoporosis
Sep 11, 2017
EVENITY(TM) (romosozumab) ARCH Study Results Published In The New England Journal Of Medicine
Sep 08, 2017
Amgen Highlights The Latest EVENITY(TM) (Romosozumab) And Prolia® (Denosumab) Research At The American Society For Bone And Mineral Research Annual Meeting